• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX23A
Device Problems Use of Device Problem (1670); Device Operates Differently Than Expected (2913)
Patient Problems No Information (3190); No Code Available (3191)
Event Date 01/22/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Edwards lifesciences continues to investigate the reported event and a supplemental report will be submitted in accordance with 21 cfr 803.56 when additional information becomes available.
 
Event Description
As reported through the edwards lifesciences implant patient registry, 44 days post implant of a 23mm sapien 3 valve in the mitral position, a 26mm sapien 3 valve was implanted.No further information is available at this time.
 
Manufacturer Narrative
This 3500a form are listed below; system updates pending.Result code: known inherent risk of procedure.Udi number: ((b)(4).The edwards sapien 3 transcatheter heart valve (thv), and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (b)(4).In this case, there is no malfunction of the sapien 3 valve, the broken suture used to secure the implanted valve maybe related to suturing technique, materials, or patient factors.The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Event Description
A 23mm sapien 3 valve was surgically implanted in the mitral position, because the planned mitral surgical valve would not fit/work.About 44 days post valve implant, follow-up echo indicated that one of the sutures used to implant the sapien 3 valve had broken.The patient was taken to surgery that same day.The 23mm sapien 3 valve was explanted and a 26mm sapien 3 valve was implanted via a right mini thoracotomy.Multiple sutures were used to secure the valve.Upon completion of the procedure, the patient was in stable condition.
 
Manufacturer Narrative
Section of this report has been updated to reflect the correct aware date for the event.The correct aware date for the event was confirmed on (b)(6) 2016 and was previously reported under follow-up 1 of this manufacturing report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
frances preston
1 edwards way
irvine, CA 92614
9492505190
MDR Report Key5500964
MDR Text Key40356871
Report Number2015691-2016-00793
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 01/22/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/26/2016
Device Model Number9600TFX23A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/29/2016
Initial Date FDA Received03/15/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received04/18/2016
10/06/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/09/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-